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Abstract Narcolepsy with cataplexy (NC) is a neuro-
logical sleep disorder characterized by very low or unde-
tectable concentration of hypocretin-1 in the cerebrospinal
fluid. It has been recently found that patients with NC have
disturbed circadian pattern of blood pressure, with more
frequent non-dipping, compared to healthy controls. It has
been hypothesized that lack of hypocretin may lead to
increase in nocturnal blood pressure. This increase may
result also from disturbed sleep architecture regardless of
the deficiency of hypocretin. The aim of this study was to
compare changes in values of daytime and nighttime blood
pressure in NC patients and in patients with disturbed
nocturnal sleep due to other sleep disorders. We have ret-
rospectively compared polysomnographic and clinical data
of 8 NC patients and 7 age- and sex controls suffering from
insomnia. We have compared sleep architecture, mean
blood pressure values and dipping pattern in both groups.
The groups did not differ in terms of disturbances of sleep
architecture. We have not found any statistical differences
in values of daytime and nocturnal blood pressure. Non-
dipping was equally frequent in both groups (87.5 and
85.7 %). Our results suggest that observed abnormalities in
circadian changes of blood pressure values result from
disturbed sleep architecture than from deficiency of
hypocretin. Patients with sleep disorders should be care-
fully observed for the presence of increased blood pressure
and other vascular risk factors.
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Introduction
Narcolepsy with cataplexy (NC) is a neurological sleep
disorder characterized by the presence of excessive day-
time sleepiness, cataplexy, hypnagogic hallucinations and
sleep paralysis. Nocturnal sleep disturbances and automatic
behaviors during the day are also present in the disease [1].
It was found that narcoleptic patients are characterized by
very low or undetectable concentration of hypocretin-1 in
the cerebrospinal fluid. Hypocretin-1 (Hcrt-1) is a neuro-
transmitter produced by neurons located in the lateral part
of hypothalamus, projecting to multiple areas of the central
nervous system and influencing the sleep–wake rhythm and
many other metabolic processes [2]. It has been also
hypothesized that hypocretin is a relevant factor in central
control of the circadian rhythm of fluctuations of the car-
diovascular system [3, 4].
One of the most prominent traits of the circadian rhythm
of the cardiovascular system is the nocturnal decrease of
the blood pressure (BP)—so-called dipping. This phe-
nomenon has a crucial clinical significance—decrease in
nocturnal values of blood pressure that below 10 % of the
daytime values (so-called non-dipping) or increase of the
BP during the night (‘‘inverse dipping’’) are major car-
diovascular risk factors [5].
Non-dipping pattern of nocturnal blood pressure was
recently found in NC patients in two studies [6, 7]. The
authors comparing NC patients with healthy controls found
that the nocturnal decrease of blood pressure is reduced in
NC patients [6] or that non-dipping is more prevalent in
narcoleptics [7]. The authors of both the studies
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hypothesized that it is the deficit of hypocretin, which
causes this abnormalities in narcoleptic patients.
Increased cardiovascular risk or non-dipping has been
found also in other sleep disorders, like insomnia [8]. It
might be hypothesized that lack of nocturnal dipping of
blood pressure in narcoleptic patients is not resulting from
deficit of hypocretin but that it is secondary to disturbed
sleep architecture.
The aim of this study was to compare changes in values
of daytime and nighttime blood pressure in NC patients and
in patients with disturbed nocturnal sleep due to insomnia.
Materials and methods
We have performed a retrospective analysis of
polysomnographic, laboratory and clinical data of 8
patients diagnosed in VitalMed Helsinki Sleep Clinic with
NC. All the patients were diagnosed according to the
International Classification of Sleep Disorders (ICSD-2)
[9]. We have analyzed the first polysomnographic record-
ing of drug-naı¨ve patients, performed during the diagnostic
process, without intake of any drugs (including anti-nar-
coleptic drugs) that might have interfered with the sleep
architecture. Data on hypocretin-1 (hcrt-1) level in the
cerebrospinal fluid and the on the haplotype HLA
DQB1*0602 were collected. Data on the comorbid disor-
ders and drug intake were taken from the patients files.
We have randomly selected 7 sex- and age-matched
controls from the patients that underwent a diagnostic
polysomnography (PSG) in VitalMed Helsinki Sleep Clinic
and were diagnosed with insomnia. We have excluded
patients diagnosed with sleep-related breathing disorders
(SRBD) as the influence of SRBD on the function of car-
diovascular system is very significant and well described.
As the NC patients, controls were free of taking any drugs
that might have altered their sleep architecture during the
PSG. Their clinical and laboratory data (including data on
hypocretin-1 level and haplotype HLA DQB1*0602, where
available) were taken from their medical files.
Data of all the patients were anonymized prior to
selection of the patients. Only archival data of the patients
were analyzed. The protocol of the study was approved by
the Independent Bioethical Committee for Scientific
Research at the Medical University of Gdansk.
Patients underwent a single polysomnographic study.
All the recordings were performed with SOMNOscreen
plus PSG system (Somnomedics, Randersacker, Germany).
Sleep recording included four EEG leads, two bilateral
electro-oculogram leads (EOG), bilateral chin elec-
tromyographic leads (EMG), two surface EMG leads
placed on the left and right anterior tibialis muscles
(recording periodic limb movements (PLMs) in sleep and
wake). Respiration was recorded with nasal cannula, tho-
racic and abdominal strains and finger oxymetry. ECG was
recorded with single precardial lead. The PSG included
beat-to-beat blood pressure measurement that was per-
formed with measurement of pulse transit time (PTT) [10].
The measurement of blood pressure was continuous, non-
invasive and not disturbing the sleep of the patients.
Recordings were scheduled to start at 09.00 PM and to
end at 06.30 AM, with 9 h and 30 min of recording. The
patients were allowed to sustain their normal activity and
were not forced to stay in bed for at least 1 h after
beginning of the recording.
The PSG recordings were scored according to American
Academy of Sleep Medicine guidelines [11]. The following
sleep parameters were calculated: total sleep time (TST);
sleep efficiency (SE); latency of stages 1, 2, slow wave
sleep (SWS) and REM sleep; duration of stages 1, 2, SWS
and REM; Sleep Stage Change Index (number of transi-
tions between the sleep stages per hour of sleep); the Wake
Index (WI) (number of awakenings per hour of sleep),
duration of Wake after Sleep Onset (WASO), PLMS index
(PLMSI).
For the assessment of the cardiovascular system the
following values were calculated: mean systolic and dias-
tolic blood pressure (SBP and DBP, respectively) during
the ‘‘day’’ (‘‘day’’ was defined as the time from the start of
recording till the ‘‘lights-off’’ moment, and from the
‘‘lights-on’’ moment till the end of recording) and during
the night (defined as the time between ‘‘lights-off’’ and
‘‘lights-on’’ moments), the difference between ‘‘day’’ and
night mean values of the SBP and DBP (delta_SBP and
delta_DBP) and the percentage of the BP values reduction
during the night (delta_SBP/SBP_day 9 100 %; del-
ta_DBP/DBP_day 9 100 %). Patients with decrease of
mean blood pressure (systolic or diastolic) during the night
smaller than 10 % of mean blood pressure during the
‘‘day’’ were considered as ‘‘non-dippers’’. Mean heart rate
(HR) during the ‘‘day’’ and the night and the ‘‘day’’-night
HR difference (delta_HR) were also calculated. Sympatho-
vagal balance (SVB) was assessed by calculating an
average ratio between low (LF) and high frequency (HF)
compononents of heart rate variability (HRV) spectra.
Results
Recordings of 8 NC patients and 7 insomnia patients were
analyzed. The demographic and clinical data of the patients
are presented in Table 1. There was 1 hypertensive patient
in the narcolepsy and in the insomnia group. None of them
was medicated when the PSG was performed.
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Data on hypocretin-1 level in cerebrospinal fluid were
available for all NC patients. Hcrt-1 was undetectable in 5
cases, and its concentration ranged from 27.00 to 69.00 in 3
cases. Data on haplotype HLA DQB1*0602 were collected
in 8 patients—all of them were positive. Data on haplotype
HLA DQB1*0602 and Hcrt-1 level in cerebrospinal fluid
were available for 4 control patients—all of them were
negative for HLA DQB1*0602 and had Hcrt-1 level above
110 pg/ml.
There were no statistically significant differences in the
sleep parameters between the groups with an exception for
longer REM latency in the NC group. The sleep parameters
of the NC patients and the control patients are presented in
Table 2.
There were no statistically significant differences
between the groups regarding mean values of blood pres-
sure and heart rate during ‘‘day’’ and night. The average
sympatho-vagal balance did not differ significantly
between the groups (Table 3).
There was a trend for less-pronounced nocturnal dipping
in the narcoleptic group although the difference did not
reach the statistical significance. The numbers of dippers
were equal in both groups (Table 4).
Table 1 Demographic and
clinical data of the studied
population
NC patients (n = 8) Controls (n = 7) P
Gender (M/F) 3/5 4/3 NS
Age (years, mean ± SD) 27.88 ± 15.39 24.29 ± 6.80 NS
BMI (mean ± SD) 25.44 ± 5.75 26.6 ± 5.36 NS
ESS (mean ± SD) 15.88 ± 4.55 9.14 ± 4.67 \0.005
Comorbidities
Hypertension [n (%)] 1 (12.5) 1 (14.3) NS
Hypercholesterolaemia [n (%)] 1 (12.5) 1 (14.3) NS
Cluster headache [n (%)] 1 (12.5) 0 (0) NS
Current smoking [n (%)] 4 (50) 4 (57.1) NS
BMI body mass index, ESS Epworth sleepiness scale
Table 2 Sleep parameters of NC patients and controls
NC patients Insomnia patients P
Total sleep time (min; mean ± SD; median) 442.8 ± 70.2; 462.6 427.2 ± 67.8; 433.8 0.34
Sleep efficiency (%) 84.41 ± 11.86 85.94 ± 11.13 0.40
S1 latency (min; mean ± SD; median) 15.6 ± 26.4; 6.0 33.0 ± 47.4; 21.0 0.19
S2 latency (min; mean ± SD; median) 32.4 ± 24.6; 22.8 42.6 ± 48.6; 42.6 0.81
SWS latency (min; mean ± SD; median) 40.2 ± 22.8; 30.6 63.0 ± 67.8; 37.8 0.19
REM latency (min; mean ± SD; median) 15.6 ± 31.2; 4.2 106.8 ± 54.0; 101.4 0.0006
S1 time (min;; mean ± SD; median) 99.0 ± 35.4; 106.2 77.4 ± 97.2; 52.2 0.28
S2 time (min; mean ± SD; median) 186.0 ± 42.6; 187.8 210.0 ± 90.0; 241.2 0.25
SWS time (min; mean ± SD; median) 73.8.0 ± 37.8; 55.2 61.2 ± 40.2; 58.8 0.27
REM time (min; mean ± SD; median) 84.6 ± 18.6; 79.8 78.6 ± 25.8; 73.2. 0.32
Sleep stage change index (mean ± SD) 18.93 ± 6.81 15.43 ± 4.45 0.13
Wake index (mean ± SD) 3.58 ± 2.64 3.01 ± 2.01 0.33
Wake after sleep onset (min; mean ± SD; median) 65.4 ± 58.2; 45.0 32.4 ± 19.2; 35.4 0.09
PLMS index (mean ± SD) 7.44 ± 6.01 2.79 ± 4.69 0.06
Sleep stage change index: number of transitions between the sleep stages per hour of sleep; wake index: number of awakenings per hour of sleep,
‘‘Wake’’ defined as appearance of at least one epoch of sleep stage ‘‘Wake’’ from any sleep stage
Table 3 Mean values of blood pressure, heart rate and sympatho-
vagal balance compared between narcolepsy and insomnia groups
NC patients Insomnia patients P
Mean ‘‘day’’ SBP ± SD 115.7 ± 12.1 116.14 ± 13.2 0.48
Mean night SBP ± SD 110.2 ± 9.5 107.4 ± 9.9 0.29
Mean ‘‘day’’ DBP ± SD 71.7 ± 7.9 70.6 ± 6.1 0.37
Mean night DBP ± SD 69.4 ± 7.2 65.7 ± 5.2 0.14
Mean ‘‘day’’ HR ± SD 75.9 ± 11.9 69.0 ± 14.5 0.16
Mean night HR ± SD 60.0 ± 3.8 60.7 ± 8.5 0.42
Mean SVB ± SD 14.8 ± 5.8 12.4 ± 2.4 0.16
SBP systolic blood pressure, DBP diastolic blood pressure, HR heart
rate, SVB sympatho-vagal balance
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Discussion
Nocturnal dipping of blood pressure is an important
physiologic phenomenon and non-dipping is a relevant risk
factor for cardiovascular diseases. That is why clarifying
the mechanisms of dipping has a crucial meaning. We have
found that narcoleptic patients do not differ statistically
from patients with insomnia in terms of values of blood
pressure and presence of non-dipping. The prevalence of
non-dipping was very high in both groups but did not differ
between them. The control group (patients with insomnia)
did not differ from the narcoleptic group in terms of
demographic traits. Both groups had similarly disturbed
nocturnal sleep. The only difference between the groups
was the etiology of sleep disorders: presence or absence of
hypocretin deficiency. The fact that we did not find any
differences in values of blood pressure and in the values of
nocturnal dipping of blood pressure between the groups
suggests that the hypocretin status does not influence the
cardiovascular parameters. High prevalence of ‘‘non-dip-
pers’’ in both groups suggest that the disorders of sleep
architecture, regardless of their etiology, may play a sig-
nificant role in increasing the cardiovascular risk.
The relation between narcolepsy and blood pressure has
been studied in animal models and the results are
ambiguous. Schwimmer et al. found that blood pressure in
narcoleptic rats is lower than in wild-type animals, which
present decrease of the values of blood pressure during
transition from wake to NREM sleep [4]. Shirasaka et al.
found that hypocretin given intracerebroventricularly to
conscious rats led to increase in the values of mean arterial
pressure in the animals [12]. A similar conclusion was
drawn after experimental injections of hypocretin to rostral
ventrolateral medulla of anesthetized rats [13] or to nucleus
tractus solitarius of anesthetized rats [14]. Matsumura et al.
found that intracerebroventricular injection of hypocretin
leads to increase of blood pressure in conscious rabbits
[15]. Microinjections of hypocretin to medullary raphe
increased heart rate and blood pressure in awake rats [16].
Recently it has been shown that blockade of central
hypocretin receptors decreases blood pressure in hyper-
tensive rats [17]. Those results suggest that in case of
deficiency of hypocretin within the central nervous system
an increase of blood pressure should not be expected. Our
finding that blood pressure in narcoleptic patients is not
higher than in patients without narcolepsy remains in line
with the above conclusions. De Oliveira et al. found that
the cardiovascular reaction (increase or decrease of the
blood pressure) to microinjections of hypocretin depends
on the site of the injection within the nucleus of solitary
tract in rats [18]. There is one study so far showing that
sleep-related dipping of blood pressure is blunted and that
blood pressure during sleep is higher in hypocretin-defi-
cient mice compared with wild-type animals [19].
Data on circadian shifts of blood pressure in patients
with narcolepsy-cataplexy are scarce and unambiguous.
Guilleimnault et al. compared nocturnal blood pressure in
narcoleptic patients and healthy controls [20]. No signifi-
cant differences were found in the values of blood pressure
and the rhythm of their changes during the night between
the groups, which is in concordance with our study. Baker
et al. have published a study with examined populations
similar to ours: narcoleptic patients were compared with
patients suffering from another sleep–wake disorder—id-
iopathic hypersomnia [21]. The authors found that NC
patients had higher values of nocturnal blood pressure than
patients with hypersomnia. This result is opposite to ours.
It must be noted that populations compared by Baker et al.
differed significantly in terms of sleep parameters. Nar-
coleptic patients had significantly more apneic/hypopneic
episodes and periodic limb movements during the night
than patients with hypersomnia, they also had shorter total
sleep time, less slow-wave sleep, more frequent awaken-
ings and lower sleep efficiency. Any of those differences
might have influenced the values of blood pressure. The
populations compared in our paper, despite the diversity of
diagnoses, had similar sleep parameters that may explain
the discrepancy in the results between studies of Baker
et al. and ours.
Narcoleptic patients in our study had higher values in
Epworth Sleepiness Scale implicating higher level of
daytime sleepiness. That could result in lower intensity of
physical activity, which in turn could lead to lower values
of blood pressure. That may partly explain the lack of
Table 4 Mean values of
nocturnal dipping of blood
pressure and prevalence of non-
dipping in narcoleptics (NC)
and insomnia patients
NC patients (n = 8) Insomnia patients (n = 7) P
Delta_SBP (mmHg) 5.5 8.7 0.23
Dipping of SBP (%) 4.4 7.0 0.23
Delta_DBP (mmHg) 2.4 4.9 0.09
Dipping of DBP (%) 3.1 6.7 0.07
Number of non-dippers 7 6 1.00
Delta_SBP decrease of systolic blood pressure during the night, Delta_DBP decrease of diastolic blood
pressure during the night
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significant difference between the daytime and nighttime
values of blood pressure in the narcoleptic patients.
Recently two studies on blood pressure and nocturnal
dipping in narcolepsy were published. Grimaldi et al. in a
study comparing 10 narcoleptic patients and 12 healthy
controls found significantly blunted decrease in blood
pressure in NC patients compared with the controls. Nar-
coleptic patients in our study had lower values of decrease in
blood pressure (Delta_SBP and Delta_DBP) but this dif-
ference did not reach statistical significance. Grimaldi et al.
were comparing narcoleptics and healthy subjects [6]. There
were some sleep parameters that significantly differed
between the groups: arousal index, periodic limbs move-
ments in sleep index and periodic limb movements in sleep
with arousal index were significantly higher in the nar-
coleptic patients and their sleep was more fragmented. The
authors stated that the blunted blood pressure dipping may
result from disrupted sleep architecture as well as from
deficiency of hypocretin. Groups compared in our study did
not differ statistically in terms of sleep parameters (as two
groups with sleep/wake disorders were compared) and this
may explain the lack of difference in nocturnal dipping.
Dauvilliers et al. performed a study comparing 50 NC
patients with 42 healthy controls [7]. The authors found that
dipping of diastolic and mean blood pressure was signifi-
cantly lower in the NC group, with significantly higher
percentage of ‘‘non-dippers’’ in the NC group. The groups
differed significantly as sleep parameters were considered:
percentage of REM sleep was higher in the NC group,
latency of REM sleep was shorter in NC sleep, wake time
after sleep onset, apnea hypopnea index, periodic limb
movements index were greater in the NC group. The authors
found associations between disturbed sleep architecture in
narcoleptic patients and the dipping of the blood pressure
and concluded that observed abnormalities in blood pressure
dipping may result from sleep disturbances typical for nar-
colepsy. This suggestion was confirmed in our study. Our
groups did not differ in terms of sleep parameters and no
difference in blood pressure dipping was found.
Our study has some limitations. It was a study with a
small number of patients and the control group was not
homogenous, which may weaken the conclusions. We were
focused on the phenotype of the disordered sleep and not on
the aetiology of the sleep disorder. That enabled us to notice
that non-dipping may be present in sleep-disordered sub-
jects, regardless of the pathomechanism of the sleep dis-
order. The retrospective character of the study allowed for
precise inclusion of the patients and controls that makes
conclusions more reliable. Data on daytime blood pressure
do not come from 24-h monitoring of blood pressure.
Values of daytime blood pressure were acquired from early
evening and early morning hours—period of less intense
activity. Due to that BP values could have been reduced and
thus influencing the values of dipping. Nevertheless, the
patients were sustaining their normal activity after begin-
ning of the recording. It must be also remembered that stay
at the sleep laboratory and a PSG study was a completely
new experience for the patients leading to some form of
arousal. Thus the recorded BP values contain information
about daytime BP values of the patients. As this limitation
applies for both compared groups, the conclusions still may
be drawn. Another limitation is lack of healthy control
group—absence of non-dipping in patients with normal
sleep would be another evidence for hypothesis that non-
dipping may result from sleep disturbances.
The strength of our study is the selection of patients. We
were analyzing PSG recordings of drug-naı¨ve and drug-
free NC patients that allows to exclude any influence of
stimulating drugs on the blood pressure values. Both
groups did not differ in terms of sleep parameters. The
clinical phenotype of disturbances in sleep architecture was
similar in both groups but the etiology of those distur-
bances was different. This allows us to conclude that lack
of nocturnal dipping of blood pressure is frequent in nar-
coleptic patients but is not more frequent than in patients
with other sleep disorder (insomnia). That suggests that it is
not the deficiency of hypocretin that leads to abnormalities
in nocturnal blood pressure but the disruption of sleep
architecture, regardless of its etiology although due to
small number of study participants it is a very preliminary
conclusion. An interesting way of verifying this hypothesis
in the future would be comparing values of nocturnal
dipping of BP in narcoleptic patients with and without
hypocretin deficiency. That requires a more strict assess-
ment of cardiovascular risk in the whole clinical population
of sleep-disordered patients.
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